Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 |
filingDate |
2019-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cd1436dcbf1b9c68566837f674cb5a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d54055ed35e81af396496644693ab7f |
publicationDate |
2021-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021355123-A1 |
titleOfInvention |
5-Morpholin-4-yl-pyrazolo[4,3-b]pyridine derivatives |
abstract |
Compounds of the formula Ia and Ib n n n n n n n n n n in which R 1 , R 2 and R 3 have the meanings indicated in claim 1 , are inhibitors of ATR, and can be employed for the treatment of diseases such as cancer. |
priorityDate |
2018-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |